Skip to content ↓

New leadership at LFM-SDM

Professors Thomas Allen and David Simchi-Levi will succeed professors Steven Eppinger and Paul Lagace as co-directors of two programs: Leaders for Manufacturing (LFM) and System Design and Management (SDM). Allen represents the Sloan School as LFM-SDM co-director, while Simchi-Levi represents the School of Engineering, effective July 1.

The change was announced by Dean of Engineering Thomas L. Magnanti and Richard L. Schmalensee, dean of the Sloan School of Management. The schools are partners in the two programs. William Hanson will continue as the third LFM-SDM co-director, representing industry.

Allen, professor of engineering systems and the Howard W. Johnson Professor of Management at Sloan, has been on the MIT faculty for 37 years. His research explores the relationship between organizational structure and behavior, the role of technological gatekeepers in technology transfer, and the influence of architectural layout on communication.

Simchi-Levi, professor of engineering systems in the Engineering Systems Division and the Department of Civil and Environmental Engineering, joined the faculty in 2000. His research focuses on supply chains, network design, inventory models, pricing and procurement strategies, and production scheduling.

A version of this article appeared in MIT Tech Talk on June 12, 2003.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story